The Black Book of Psychotropic Dosing and Monitoring

Overview

Journal Psychopharmacol Bull

Specialty Pharmacology

Date 2018 Feb 1

PMID 29382960

Authors

Alan F Schatzberg

DeBattista Charles

Affiliations

Soon will be listed here.

References

Malik R, Sangwan A, Saihgal R, Jindal D, Piplani P . Towards better brain management: nootropics. Curr Med Chem. 2007; 14(2):123-31. DOI: 10.2174/092986707779313408. View

Milne M, Crouch B, Caravati E . Buprenorphine for opioid dependence. J Pain Palliat Care Pharmacother. 2009; 23(2):153-5. DOI: 10.1080/15360280902900869. View

Zarate Jr C, Tohen M, Banov M, Weiss M, Cole J . Is clozapine a mood stabilizer?. J Clin Psychiatry. 1995; 56(3):108-12. View

Rodebaugh T, Lenze E . Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy. J Clin Psychiatry. 2013; 74(4):415-6. DOI: 10.4088/JCP.13ac08464. View

Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K . Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2013; 171(2):160-8. DOI: 10.1176/appi.ajp.2013.13070984. View

Kiayias J, Vlachou E, Lakka-Papadodima E . Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care. 2000; 23(5):699. DOI: 10.2337/diacare.23.5.699b. View

Lindenmayer J, Klebanov R . Olanzapine-induced manic-like syndrome. J Clin Psychiatry. 1998; 59(6):318-9. DOI: 10.4088/jcp.v59n0608c. View

Schatzberg A, Cole J . Benzodiazepines in depressive disorders. Arch Gen Psychiatry. 1978; 35(11):1359-65. DOI: 10.1001/archpsyc.1978.01770350085008. View

Birks J, McGuinness B, Craig D . Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev. 2013; (5):CD004744. DOI: 10.1002/14651858.CD004744.pub3. View

10.

Keck Jr P, Mintz J, McElroy S, Freeman M, Suppes T, Frye M . Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006; 60(9):1020-2. DOI: 10.1016/j.biopsych.2006.03.056. View

11.

Wender P, Reimherr F, Wood D, Ward M . A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985; 142(5):547-52. DOI: 10.1176/ajp.142.5.547. View

12.

Lucca A, Serretti A, Smeraldi E . Effect of reboxetine augmentation in SSRI resistant patients. Hum Psychopharmacol. 2002; 15(2):143-145. DOI: 10.1002/(SICI)1099-1077(200003)15:2<143::AID-HUP152>3.0.CO;2-N. View

13.

Ayd F . Ethical and legal dilemmas posed by tardive dyskinesia. Int Drug Ther Newsl. 1977; 12(8-9):29-36. View

14.

Vieta E, Herraiz M, Fernandez A, Gasto C, Benabarre A, Colom F . Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). J Clin Psychiatry. 2001; 62(8):623-30. DOI: 10.4088/jcp.v62n0809. View

15.

Tohen M, Vieta E, Calabrese J, Ketter T, Sachs G, Bowden C . Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003; 60(11):1079-88. DOI: 10.1001/archpsyc.60.11.1079. View

16.

. Nefazodone for depression. Med Lett Drugs Ther. 1995; 37(946):33-5. View

17.

Green A, Tohen M, Patel J, Banov M, Durand C, Berman I . Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry. 2000; 157(6):982-6. DOI: 10.1176/appi.ajp.157.6.982. View

18.

Keppel Hesselink J, de Jongh P . Sertraline in the prevention of depression. Br J Psychiatry. 1992; 161:270-1. DOI: 10.1192/bjp.161.2.270. View

19.

Both C, Kojda G, Lange-Asschenfeldt C . Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin. Expert Rev Neurother. 2013; 14(1):29-38. DOI: 10.1586/14737175.2014.853617. View

20.

Levenson J . Neuroleptic malignant syndrome. Am J Psychiatry. 1985; 142(10):1137-45. DOI: 10.1176/ajp.142.10.1137. View